Form 4: Carisma Therapeutics Inc. Director Michael Torok Acquires Stock Options
SEC Form 4 Filing
Director Michael Torok acquired 19,350 stock options in Carisma Therapeutics Inc. on June 26, 2024.
Summary
- Michael Torok, a director of Carisma Therapeutics Inc., acquired 19,350 stock options on June 26, 2024.
- The options have an exercise price of $1.22.
- The options vest on the first anniversary of the grant date or immediately prior to the first annual meeting of stockholders after the grant date, contingent on continued service as a director.
- The expiration date for these options is June 26, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard transaction filing, indicating insider activity but not necessarily positive or negative news.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is crucial for maintaining market integrity and investor confidence.
Key Dates
| Date | Description |
|---|---|
| 06/26/2024 | Date of transaction: Michael Torok acquired stock options. |
| 06/27/2024 | Date of signature on the Form 4 filing. |
| 06/26/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.